Sign in

You're signed outSign in or to get full access.

Brian Baker

Brian Baker

President, Chief Executive Officer, and Chief Financial Officer at DYNATRONICS
CEO
Executive
Board

About Brian Baker

Brian D. Baker is President, Chief Executive Officer, Chief Financial Officer, and a Director of Dynatronics. He is 59, a director since 2023, and holds a B.A. in business from the University of Phoenix . He became CEO effective October 1, 2023, President in May 2023, and CFO in May 2025 . Prior roles include VP Global Operations at SeaSpine and VP Operations at Integra’s SeaSpine business . Pay-versus-performance disclosures show cumulative TSR value of $24.60 in 2023 dropping to $2.70 in 2025 and net losses of ($4,973k), ($2,698k), and ($10,902k) for 2023–2025, respectively, during a turnaround period .

Past Roles

OrganizationRoleYearsStrategic Impact
DynatronicsPresident, Therapy ProductsFeb 2018Brought operating leadership into therapy products segment
DynatronicsChief Operating OfficerMay 2019 – Aug 2019Promoted to CEO; operations leadership
DynatronicsChief Executive OfficerAug 2019 – Jul 2020Led company; resigned due to COVID-related health issues
DynatronicsDirector and ConsultantJul 2020 – Jan 2022Continued contributions to strategy/governance
DynatronicsChief Operating OfficerJan 2022 – Oct 1, 2023Returned to operating leadership
DynatronicsPresidentMay 2023 – presentElevated commercial focus
DynatronicsChief Executive OfficerOct 1, 2023 – presentCurrent PEO
DynatronicsChief Financial OfficerMay 2025 – presentAdded PFO responsibilities

External Roles

OrganizationRoleYearsStrategic Impact
SeaSpine HoldingsVP, Global OperationsJul 2015 – Jan 2018Supply chain/ops leadership in medtech
Integra LifeSciences (SeaSpine business)VP, OperationsMar 2015 – Jul 2015Ops leadership during transition
IndependentIndustry ConsultantNov 2013 – Mar 2015M&A advisory and process optimization

Fixed Compensation

YearBase Salary ($)Bonus ($)Stock Awards ($)All Other Comp ($)Notes
2024248,58211,2909,28413,123Employee director; no separate director pay
2025200,09213,302Base rate cut to $150,000 effective 3/24/2025

Performance Compensation

Incentive program and awards

  • CD&A indicates executive pay includes base salary and equity; bonuses are determined by performance goals, but specific metrics/weights are not disclosed .
  • Employment Agreement terms: eligibility for annual RSUs valued at $75,000, vesting 50% on grant and 50% at first anniversary; initial contemplated grants: 50,000 RSUs (25% annually over 4 years) and 15,000 stock options (market strike) considered at the next Compensation Committee meeting .
  • FY2025: Mr. Baker received no equity grants .
Award/MetricTarget/GrantVestingActual/PayoutStatus/Notes
Annual RSU eligibility$75,000 RSUs per year50% on grant; 50% at 1-yearNo FY2025 grantFrom Employment Agreement; no 2025 awards
Initial RSU (contemplated)50,000 RSUs25% annually over 4 yearsN/ATo be considered by committee per 8-K
Initial Options (contemplated)15,000 optionsService-vest per awardN/ATo be considered; market strike
Outstanding options (as of 6/30/25)18,000 exercisableVestedN/AStrikes $6.95–$13.50; expire 2/26/26–8/25/27
Cash bonusNot disclosed (target)N/A$11,290 (2024)No 2025 bonus disclosed

Performance metrics table (disclosed)

MetricWeightingTargetActualPayoutVesting
Company/Individual goals (bonus)Not disclosedNot disclosedNot disclosed$11,290 (FY2024)N/A

Equity Ownership & Alignment

Security/ClassAmountOwnership %Notes
Common stock (beneficial)364,2602.3%Based on 16,001,331 shares outstanding (10/10/2025)
Series A Preferred (as-converted)96,0004.8%As-converted voting basis; see table notes
Series B Preferred (as-converted)19,200Convertible equivalent included in total per footnote
Options exercisable18,000Vested; strikes $6.95–$13.50; expiry 2026–2027
Total beneficial shares401,4602.5% (total voting power)Per beneficial ownership table and footnote
  • Pledging/hedging: Company prohibits pledging and hedging by executives and directors; short sales and margin also prohibited .
  • Stock ownership guidelines: Not disclosed in proxy .

Employment Terms

TermDetail
CEO start dateOctober 1, 2023
President start dateMay 18, 2023
CFO start dateMay 9, 2025
Base salary (initial)$212,000 under Employment Agreement
Salary changeReduced to $150,000 effective March 24, 2025
Annual equity eligibility$75,000 RSUs; 50% on grant, 50% at 1-year
Severance (no-cause, first 12 months)90 days’ base salary; 50% of Initial Awards vest (if applicable), subject to release
Change-in-Control (CIC)Lump-sum 2.5x base salary within 10 business days post-CIC; no 280G gross-up (“best-net” cap); term extended through April 2028
Restrictive covenants12-month non-compete; 2-year non-solicit; confidentiality
ClawbackCompany adopted clawback policy compliant with Section 10D; applies to equity and cash incentives
At-willEmployment is at-will under the agreement

Board Governance

  • Board service: Director since 2023; not independent due to executive role .
  • Leadership: Independent Chair (Erin S. Enright); roles of Chair and CEO are separated .
  • Committees (FY2025): Baker is not on committees; Audit: Holtz (Chair), Enright, Hulett; Nominating, Governance and Compensation (NGC): Enright (Chair), Ward, Hulett .
  • Meetings: Board met 5 times in FY2025; each director attended ≥75%; 5 executive sessions of independent directors .
  • Director compensation: Employee directors receive no additional pay for board service .

Performance & Track Record

Pay vs Performance context (proxy)

Metric202320242025
Value of $100 investment (TSR)$24.60$8.69$2.70
Net Income (Loss) ($000s)(4,973)(2,698)(10,902)

Company financials across tenure

Metric (USD)FY 2022FY 2023FY 2024FY 2025
Revenues$44,338,490*$40,609,372*$32,533,965*$27,393,163*
EBITDA($3,521,143)*($3,502,827)*($969,342)*($1,347,997)*

Values retrieved from S&P Global.*

Compensation Structure Analysis

  • Mix and metrics: Program is primarily base salary plus limited equity; significant portion of any bonus is performance-based, but specific financial/operational metrics and weights are not disclosed—limiting pay-for-performance transparency .
  • Equity design: Annual RSU eligibility ($75k) is service-vested (50/50); initial contemplated RSUs/options featured multi-year vesting; FY2025 included no new equity grants to Baker, reducing near-term vesting overhang .
  • Cost actions: CEO base reduced to $150,000 effective March 24, 2025, signaling cost discipline/liquidity preservation .
  • CIC economics: 2.5x base salary, immediate lump sum, no tax gross-up (best-net), through April 2028—meaningful protection that could influence transaction dynamics .
  • Clawback, hedging/pledging bans: Strengthens alignment and risk controls relative to shareholder interests .

Risk Indicators & Red Flags

  • Dual-role concentration: CEO concurrently serving as CFO (since May 2025) concentrates financial control; mitigated by independent Chair and independent Audit Committee with financial experts .
  • Limited metric disclosure: Lack of disclosed incentive metrics/targets reduces visibility into pay-for-performance rigor .
  • CIC payout leverage: 2.5x base (no bonus multiple) is significant for a micro-cap; no 280G gross-up (positive governance) .
  • Insider trading controls: Prohibitions on pledging, hedging, and short sales reduce misalignment risk .

Say-on-Pay & Compensation Committee Practices

  • Say-on-Pay frequency: Board recommends triennial “Say-When-on-Pay” votes to better align with multi-year equity vesting .
  • Consultant usage: No compensation consultant engaged in FY2025 .

Equity Vesting & Insider Selling Pressure

  • As of June 30, 2025, Baker held 18,000 fully vested options (strikes $6.95–$13.50, expiring 2026–2027) and no unvested stock awards—implying limited automatic vest-driven selling pressure in the near term .
  • FY2025: no equity grants to Baker, further reducing near-term vesting-related supply .

Employment & Contracts – Additional Details

  • Severance (first 12 months): 90 days’ salary plus 50% vesting of Initial Awards (if applicable), subject to release .
  • Non-compete/non-solicit: 12-month non-compete; 2-year non-solicit; post-termination confidentiality preserved .
  • Indemnification and D&O coverage provided .

Investment Implications

  • Alignment: Baker owns ~2.5% of total voting power (including preferred as-converted and options), with bans on pledging/hedging—supportive of alignment, though the program’s disclosure lacks explicit financial performance targets .
  • Retention and incentives: No FY2025 equity grant and a temporary salary reduction suggest near-term focus on cash preservation; multi-year vesting design (when used) supports retention, while CIC protection (2.5x base) is sizable for a micro-cap and could influence change-of-control negotiations .
  • Governance checks: Independent Chair and financially expert Audit Committee provide oversight amid CEO/CFO dual role, but the concentration of roles elevates key-person and control risks .
  • Performance baseline: TSR deterioration and continued net losses underscore execution risk and the necessity of operational improvements; absence of disclosed incentive metrics limits visibility into whether incentives directly target revenue growth, margin expansion, or TSR recovery .
Citations: 
[6:x] refers to the October 2, 2023 8-K and its exhibits. 
[26:x] refers to the 2025 DEF 14A proxy statement.